The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
MilliporeSigma has opened a new $20-million 3,800-square-meter laboratory in Singapore for biologic testing services. The new lab complex involves the company’s BioReliance biosafety testing services as well as its M Lab Collaboration Center, which...
Lonza has invested CHF 400 million ($414 million) to add two new biomanufacturing services (Ibex Design and Ibex Develop) as part of its Ibex Solutions package from the company’s 100,000-square meter biopark in Visp, Switzerland.
Lonza’s first...
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, plans to establish a new process development and manufacturing facility at its facility in Chiba, Japan. This move is part of the...
Evonik, a specialty and fine chemical producer, has completed a EUR 36-million ($42-million) expansion of its contract manufacturing capabilities in the US and Europe. A series of technologies, including high-potency active pharmaceutical...
Wacker, a Munich, Germany-based chemical company, has expanded its biologics production facilities in Jena, Germany, with a new microbiology laboratory and equipment for process and product characterization.
“In recent years, we have been...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has completed its acquisition of Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, for approximately...
PCI Pharma Services (PCI) has agreed to acquire Sherpa Clinical Packaging (Sherpa), a San Diego, California-based provider of clinical-trial supply services. The addition of Sherpa’s capabilities enables PCI to support customers from early phases...
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has acquired Sandoz’s sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of...
Thermo Fisher Scientific has agreed to acquire the advanced bioprocessing business of Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company.
The bioprocessing business combines a technical services...
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego.
The...
Olon S.p.A., an Italy-headquartered contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and a generics supplier, has acquired a local generics chemical operations API manufacturing facility in Mahad,...
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, is increasing manufacturing capacity at its Copenhagen, Denmark facility.
The Copenhagen facility will add a single-use bioreactor...
Kaneka Corporation, a Tokyo-headquartered chemical manufacturing company, has installed continuous manufacturing equipment for small-molecule pharmaceutical products at Kaneka’s Singapore facility. Kaneka announced the installment in July 2018 and...
Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, has agreed to acquire Sensile Medical AG, an Olten, Switzerland-based medical technology company, in a deal worth up to EUR 350 million ($409...
Sterigenics, a provider of contract sterilization, gamma technologies and medical isotopes, is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
The new 60,000-square-foot facility will include the installation of a...
